Home NDC 81749-004
Tarpeyo
Product NDC 81749-004
11-digit product format 817490004
Labeler code 81749
Product ID 81749-004_48e9b876-94c8-7c9f-e063-6294a90adcef
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name budesonide
Dosage form CAPSULE, DELAYED RELEASE
Route ORAL
Labeler Calliditas Therapeutics AB
Application NDA215935
Marketing category NDA
Marketing start 2021-12-15
Substance BUDESONIDE
Active strength 4 mg/1
Pharmacologic classes Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base Tarpeyo
Listing expiration 2027-12-31
Active Ingredients# Ingredient, Strength table Ingredient Strength BUDESONIDE 4 mg/1
Harmonized Identifiers# Field, Values table Field Values Unii Q3OKS62Q6X Rxcui 2587883, 2587889
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 81749-004-01 Tarpeyo 120 in 1 BOTTLE CAPSULE, DELAYED RELEASE 120 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 81749-004 TARPEYO (BUDESONIDE) CAPSULE, DELAYED RELEASE [CALLIDITAS THERAPEUTICS AB] 4 Current NDC, Legacy NDC, 1 package rows 20240619_938cada4-d6bf-4252-836f-dd40f9eadb4d.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 81749-004-01 81749000401 120 CAPSULE, DELAYED RELEASE in 1 BOTTLE (81749-004-01) 2021-12-15 0000-00-00 No No Current